RJX

· Reven Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RJX, covering 2022-03-15 to 2022-03-15. Get the full timeline:

Most recent: Clinical Trial Update: Tolerability and Efficacy of RJX in Patients With COVID-19 [Phase 1, Phase 2]